COMPANY

OmniaMed Co., Ltd. opens up a new paradigm for the development of treatments using Nitric Oxide functionality.

LEADERSHIP

ORGANIZATION

ADVISOR

Seung-Kew Yoon Technical Adviser
  • Chief of Seoul St. Mary's Hospital at Catholic University
  • Chief of Yeouido St. Mary's Hospital at Catholic University
Hyung-Dal, PARK Patent Adviser
  • Doctor of Engineering at JAIST
  • IPCJ President Patent Attorney
In-Kyu Park Technical Adviser
  • Professor of Chonnam National University Medical School
Jeong Hun Kim Clinical Adviser
  • Professor of Clinical Science at Seoul National University
  • Clinical Professor of Ophthalmology at Seoul National University